The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome

被引:20
|
作者
Dawood, Alaaeldin [1 ]
Alkafrawy, Nabil [1 ]
Saleh, Said [2 ]
Noreldin, Rasha [3 ]
Zewain, Shimaa [1 ]
机构
[1] Menoufia Univ, Internal Med, Shibin Al Kawm, Egypt
[2] Menoufia Univ, Obstet & Gynecol, Fac Med, Shibin Al Kawm, Egypt
[3] Menoufia Univ, Clin Pathol, Shibin Al Kawm, Egypt
关键词
Polycystic ovary; interleukin-18; cardiovascular disease risk; INSULIN-RESISTANCE; INTERLEUKIN-18; MARKERS; INFLAMMATION; PCOS;
D O I
10.1080/09513590.2017.1395835
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. The evidence in support of low-grade inflammation in PCOS as an etiology is emerging. Inflammation is likely to be associated with other prominent aspects of PCOS including insulin resistance (IR) and cardiovascular disease (CVD) risk. Interleukin-18 (IL-18) is considered as a strong marker of inflammation.Objectives: Evaluation of the relation between serum IL-18 and atherosclerotic CVD (ASCVD) risk in Egyptian lean females with PCO.Methods: This study included control group of healthy lean normally menstruating females, lean PCOS group (BMI<25kg/m(2)), and obese PCOS group (BMI>25kg/m(2)) presented with infertility and diagnosed according to Rotterdam criteria. Measurements of serum lipid profile, IR, and IL-18 were done.Results: Lipid accumulation product (LAP), IR and ASCVD risk were significantly higher in PCOS patients (lean and obese) compared to controls and in obese compared to lean. Serum IL-18 was significantly higher in the PCOV groups compared to the controls and correlated directly with LAP, IR and ASCVD risk.Conclusion: IL-18 is elevated in PCOS patients even in lean ones and is correlated with IR and ASCVD risk.
引用
收藏
页码:294 / 297
页数:4
相关论文
共 50 条
  • [31] Cardiovascular risk in obese women with polycystic ovary syndrome: A Framingham Scoring
    Bozic, I.
    Macut, D.
    Popovic, B.
    Isailovic, T.
    Petakov, M.
    Ognjanovic, S.
    Damjanovic, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 126 - 126
  • [32] Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome
    Bicer, Merve
    Guler, Asli
    Kocabas, Gokcen Unal
    Imamoglu, Cetin
    Baloglu, Ali
    Bilgir, Oktay
    Yuksel, Arif
    Bozkaya, Giray
    Calan, Mehmet
    ENDOCRINE RESEARCH, 2017, 42 (02) : 145 - 153
  • [33] Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome
    Cascella, Teresa
    Palomba, Stefano
    De Sio, Ilario
    Manguso, Francesco
    Giallaurias, Francesco
    De Simone, Biagio
    Tafuri, Domenico
    Lombardi, Gaetano
    Colao, Annamaria
    Orio, Francesco
    HUMAN REPRODUCTION, 2008, 23 (01) : 153 - 159
  • [34] Polycystic Ovary Syndrome: A Major Unrecognized Cardiovascular Risk Factor in Women
    Alexander, Carolyn J.
    Tangchitnob, Edward P.
    Lepor, Norman E.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2009, 10 (02) : 83 - 90
  • [35] Cardiovascular disease risk in young Indian women with polycystic ovary syndrome
    Guleria, A. K.
    Syal, S. K.
    Kapoor, A.
    Kumar, S.
    Tiwari, P.
    Dabadghao, P.
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (01) : 26 - 29
  • [36] The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women
    Ilie, Ioana R.
    Pepene, Carmen E.
    Marian, Ioan
    Mocan, Teodora
    Hazi, Georgeta
    Dragotoiu, Gheorghe
    Ilie, Razvan
    Mocan, Lucian
    Duncea, Ileana
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2011, 6 (01): : 64 - 75
  • [37] Cigarette Smoking and Cardiovascular Risk in Young Women with Polycystic Ovary Syndrome
    Morotti, Elena
    Battaglia, Bruno
    Fabbri, Raffaella
    Paradisi, Roberto
    Venturoli, Stefano
    Battaglia, Cesare
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2014, 7 (04) : 301 - 312
  • [38] The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
    Dawson, Alison J.
    Sathyapalan, Thozhukat
    Vince, Rebecca
    Coady, Anne-Marie
    Ajjan, Ramzi A.
    Kilpatrick, Eric S.
    Atkin, Stephen L.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [39] Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study
    Mancini, Fulvia
    Cianciosi, Arianna
    Persico, Nicola
    Facchinetti, Fabio
    Busacchi, Paolo
    Battaglia, Cesare
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (02) : 169.e1 - 169.e8
  • [40] Correlations between serum sirtuin levels and cardiovascular risk factors in women with polycystic ovary syndrome
    Charazka, Beata
    Siejka, Agnieszka
    ADVANCES IN MEDICAL SCIENCES, 2022, 67 (01): : 123 - 128